Latest Insider Transactions at Supernus Pharmaceuticals, Inc. (SUPN)
This section provides a real-time view of insider transactions for Supernus Pharmaceuticals, Inc. (SUPN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of SUPERNUS PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of SUPERNUS PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 05
2020
|
Gregory S Patrick Sr. VP Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+9.18%
|
$60,000
$12.98 P/Share
|
|
Oct 15
2020
|
Gregory S Patrick Sr. VP Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-25.23%
|
$300,000
$20.03 P/Share
|
|
Oct 15
2020
|
Gregory S Patrick Sr. VP Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+20.14%
|
$180,000
$12.98 P/Share
|